Mozhi Wang
Shenyang, 110001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 30 publications
Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial.
Journal: Signal transduction and targeted therapy
Published: November 25, 2024
Primary tumor resection in de novo metastatic breast cancer from an oligometastatic perspective: A systematic review and meta-analysis.
Journal: iScience
Published: August 23, 2024
Phase separation in DNA damage response: New insights into cancer development and therapy.
Journal: Biochimica et biophysica acta. Reviews on cancer
Published: July 22, 2024
ACSL3 regulates breast cancer progression via lipid metabolism reprogramming and the YES1/YAP axis.
Journal: Cancer biology & medicine
Published: July 02, 2024
Multiple time points for detecting circulating tumor DNA to monitor the response to neoadjuvant therapy in breast cancer: a meta-analysis.
Journal: BMC cancer
Published: March 06, 2024
The Role of Breast Cancer Cells in Bone Metastasis: Suitable Seeds for Nourishing Soil.
Journal: Current osteoporosis reports
Published: December 18, 2023
PROS1, a clinical prognostic biomarker and tumor suppressor, is associated with immune cell infiltration in breast cancer: A bioinformatics analysis combined with experimental verification.
Journal: Cellular signalling
Published: June 09, 2023
KLHL29-mediated DDX3X degradation promotes chemosensitivity by abrogating cell cycle checkpoint in triple-negative breast cancer.
Journal: Oncogene
Published: April 27, 2023
A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity.
Journal: Cancer biology & medicine
Published: March 27, 2023
Last Updated: 09/26/2026